China makes strides toward abolishing animal testing

Published: 11-Oct-2013
Regulatory

The CFDA intends to release a draft of the amended regulation by the end of 2013

You need to be a subscriber to read this article.
Click here to find out more.
China makes strides toward abolishing animal testing

The China Food and Drug Administration (CFDA) has invited comments on its Regulations Concerning the Hygiene Supervision Over Cosmetics report, which the agency plans to amend for the first time in 23 years. According to Chinese sources, the rapid development of China’s cosmetics industry combined with changes in the industry, social environment and regulatory areas have rendered existing legislation inadequate.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Regulatory
Procter & Gamble drops claims on Braun IPL device following Italian competition authority investigation

Procter & Gamble drops claims on Braun IPL device following Italian competition authority investigation

Read more
The investigation by Italy’s competition authority, Autorità Garante della Concorrenza e del Mercato (AGCM), was into the company’s adverts for a Braun hair removal device, which it said may have misled consumers

Trending Articles

  1. Perfumer Francis Kurkdjian restores 13 iconic Dior fragrances for Dioriginals collection French luxury fashion house Dior and its Perfume Creation Director Francis Kurkdjian have been inspired by nearly 80 years of fragrance archives to restore iconic Dior scents, such Diorama, Diorissimo and Dioressence
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Judge dismisses L’Oréal benzene contamination lawsuit A lawsuit related to claims of benzene contamination of CeraVe and La Roche-Posay acne treatments has been dismissed by the US District Court for the Southern District of New York last week
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Microneedling regulation: When does a cosmetic product become a medical device? As demand for microneedling rises fast across both the cosmetics industry and the aesthetics space, CE.Way’s Laura Silva reports on where cosmetic care ends and medical device regulation begins
  4. Procter & Gamble drops claims on Braun IPL device following Italian competition authority investigation The investigation by Italy’s competition authority, Autorità Garante della Concorrenza e del Mercato (AGCM), was into the company’s adverts for a Braun hair removal device, which it said may have misled consumers
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Allies of Skin voluntarily recalls sunscreen over sunburn risk The skin care brand has recalled its The One SPF 50 Invisible Sunscreen Gel because it may not reliably provide the protection stated on the label

Upcoming event

Brand Licensing Europe 2026

6 - 8 October 2026 | London See all

You may also like

Regulatory
Procter & Gamble drops claims on Braun IPL device following Italian competition authority investigation

Procter & Gamble drops claims on Braun IPL device following Italian competition authority investigation

The investigation by Italy’s competition authority, Autorità Garante della Concorrenza e del Mercato (AGCM), was into the company’s adverts for a Braun hair removal device, which it said may have misled consumers
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
Microneedling regulation: When does a cosmetic product become a medical device?

Microneedling regulation: When does a cosmetic product become a medical device?

As demand for microneedling rises fast across both the cosmetics industry and the aesthetics space, CE.Way’s Laura Silva reports on where cosmetic care ends and medical device regulation begins
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
Foundation reformulation enters new era ahead of D5 and D6 cyclic silicone bans in 2027

Foundation reformulation enters new era ahead of D5 and D6 cyclic silicone bans in 2027

As new EU restrictions on cyclosiloxanes D5 and D6 take effect in 2027, formulators face challenges and opportunities in reformulating foundations without them
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
Judge dismisses L’Oréal benzene contamination lawsuit

Judge dismisses L’Oréal benzene contamination lawsuit

A lawsuit related to claims of benzene contamination of CeraVe and La Roche-Posay acne treatments has been dismissed by the US District Court for the Southern District of New York last week
Regulatory
Symrise takes home the prize at inaugural awards

Symrise takes home the prize at inaugural awards

Judge Stewart Long praised their risk assessment approach to protect against harmful exposure to chemicals, without reliance on animal testing.
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
Neutrogena launches ‘new generation’ of BEMT-powered sunscreens

Neutrogena launches ‘new generation’ of BEMT-powered sunscreens

The US is entering a new era of sunscreens after the US Food and Drug Administration (FDA) approved bemotrizinol (BEMT), the first new UV filter in more than 25 years – Neutrogena’s new formulations are among the first to hit the market with the new ingredient
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients
L’Oréal faces lawsuit in the US over hair relaxer cancer risk links

L’Oréal faces lawsuit in the US over hair relaxer cancer risk links

The Arizona, US, Attorney General's Office claims the beauty giant and its subsidiary Softsheen-Carson failed to disclose alleged cancer risks linked to hair relaxers from its brands such as Dark and Lovely, Optimum and Mizani in a new lawsuit. L’Oréal has responded stating the allegations ‘have neither legal nor scientific merit’
Subscribe now